Coronary heart disease is the single most important cause of death in our society, incurring enormous costs both in human and financial terms. The underlying disease process is atherosclerosis, an inflammatory response to endothelial injury. Fortunately, pharmaceutical products for lipid-lowering and coronary artery stents are available to cardiologists in order to produce a reversal, a regression of atherosclerotic disease, thus helping to lower the rates for sudden death, myocardial infarction and angina pectoris. The ...
Read More
Coronary heart disease is the single most important cause of death in our society, incurring enormous costs both in human and financial terms. The underlying disease process is atherosclerosis, an inflammatory response to endothelial injury. Fortunately, pharmaceutical products for lipid-lowering and coronary artery stents are available to cardiologists in order to produce a reversal, a regression of atherosclerotic disease, thus helping to lower the rates for sudden death, myocardial infarction and angina pectoris. The authors neatly summarize all coronary risk factors and treatments to reduce them.
Read Less
